Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target

Bladder cancer remains a prevalent and challenging malignancy. Myeloid-derived suppressor cells (MDSCs) have emerged as key contributors to the immunosuppressive tumor microenvironment, facilitating tumor progression, immune evasion, and resistance to therapies. This review explores the role of MDSC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Clément Klein, Samy Mebroukine, Mathilde Madéry, Alexandra Moisand, Thomas Boyer, Nicolas Larmonier, Grégoire Robert, Charlotte Domblides
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Series:	Cells
Subjects:	myeloid-derived suppressor cells bladder cancer tumor microenvironment immune inhibition biomarker immunotherapy
Online Access:	https://www.mdpi.com/2073-4409/13/21/1779
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The effect of conditioned media on the cellular proliferation of pancreatic cancer cells, pancreatic stellate cells, and myeloid-derived suppressor cells
by: Y. Chong, et al.
Published: (2025-01-01)

EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment
by: Tian Xia, et al.
Published: (2024-12-01)

Targeting folate cycle enhances effects of cancer immunotherapy by modulating myeloid-derived suppressor cells
by: HE Rui, et al.
Published: (2024-08-01)

Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
by: Shin Young Hyun, et al.
Published: (2020-10-01)

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation
by: Chunxiao Li, et al.
Published: (2025-01-01)

WNT2 blockade augments antitumor immunity by attenuating myeloid‐derived suppressor cells in colorectal cancer
by: Cheng Cui, et al.
Published: (2024-12-01)

Effects of different hypoxia exposure on myeloid-derived suppressor cells in mice
by: Qiying Xu, et al.
Published: (2024-12-01)

IRF4 regulates myeloid-derived suppressor cells expansion and function in Schistosoma japonicum-infected mice
by: Lu Zhou, et al.
Published: (2024-11-01)

Myeloid-Derived Suppressor Cells (MDSCs) and Obesity-Induced Inflammation in Type 2 Diabetes
by: Larisa Ghemiș, et al.
Published: (2024-11-01)

Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function
by: Carlo P. Ramil, et al.
Published: (2024-12-01)

HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
by: Zhiqi Xie, et al.
Published: (2025-02-01)

Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy
by: Nada Mohamady Farouk Abdalsalam, et al.
Published: (2024-11-01)

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
by: Christin Knickmeier, et al.
Published: (2025-01-01)

Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer
by: Erin M. Dickey, et al.
Published: (2024-12-01)

MDSC: a new potential breakthrough in CAR-T therapy for solid tumors
by: Nada Mohamady Farouk Abdalsalam, et al.
Published: (2024-12-01)

Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer
by: Dingshan Deng, et al.
Published: (2024-11-01)

Shuangshen Granules Suppress Myeloid-derived Suppressor Cell-mediated Lung Premetastatic Niche Development by Targeting Sphingosine-1-Phosphate Receptor-1/Signal Transducer, Activator of Transcription 3 Signaling
by: Rui Liu, et al.
Published: (2024-12-01)

S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs
by: Juan Li, et al.
Published: (2024-12-01)

Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer
by: Xiaolin Lu, et al.
Published: (2024-11-01)

Integration of Graph Neural Networks and multi-omics analysis identify the predictive factor and key gene for immunotherapy response and prognosis of bladder cancer
by: Shuai Ren, et al.
Published: (2024-12-01)

Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
by: José L. Solórzano, et al.
Published: (2024-12-01)

Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
by: Annalisa Adamo, et al.
Published: (2023-12-01)

Co-inhibition of TGF-β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance
by: Reshmi Nair, et al.
Published: (2024-12-01)

ROLE OF HETEROZYGOUS TUMOR SUPPRESSORS IN THE LIFE LONGEVITY OF DROSOPHILA MELANOGASTER
by: S. A. Kopyl, et al.
Published: (2015-01-01)

Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation
by: Jieru Yang, et al.
Published: (2025-01-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Recurrent disruption of tumour suppressor genes in cancer by somatic mutations in cleavage and polyadenylation signals
by: Yaroslav Kainov, et al.
Published: (2024-12-01)

Exploring the Immunoresponse in Bladder Cancer Immunotherapy
by: Inmaculada Ruiz-Lorente, et al.
Published: (2024-11-01)

Infant acute myeloid leukemia: insights into the biology and therapy
by: Xiaoli Chen, et al.
Published: (2024-12-01)

Gr-1 blockade remodels the immunosuppressive microenvironment induced by incomplete microwave ablation of hepatocellular carcinoma
by: Tian Huang, et al.
Published: (2024-12-01)

Disulfidptosis-related lncRNA signature to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia
by: Yuying Zhao, et al.
Published: (2024-12-01)

Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition
by: Julia Koerner, et al.
Published: (2023-12-01)

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
by: Antonino Glaviano, et al.
Published: (2025-01-01)

Single-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia
by: Guangfeng He, et al.
Published: (2024-12-01)

Germline Variants in Proto-Oncogenes and Tumor Suppressor Genes in Women with Cervical Cancer
by: Ksenia Lenkova, et al.
Published: (2024-10-01)

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma
by: Kangqiang Peng, et al.
Published: (2024-12-01)

The inhibitory effect of intraspinal microstimulation of the sacral spinal cord on nonlinear bladder reflex dynamics in cats
by: Amirhossein Qasemi, et al.
Published: (2025-02-01)

EAF2: a tumor suppressor gene with multi-aspect functions
by: Wen-Tong Ji, et al.
Published: (2024-11-01)

Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation
by: Mariane Cristina do Nascimento, et al.
Published: (2024-12-01)